世界のイボシデニブ薬市場予測2023-2029：60錠、30錠

【英語タイトル】Ivosidenib Drugs Market, Global Outlook and Forecast 2023-2029

・商品コード：MMG23LY8528
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：78
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のイボシデニブ薬市場規模と予測を収録しています。・世界のイボシデニブ薬市場：売上、2018年-2023年、2024年-2029年
・世界のイボシデニブ薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のイボシデニブ薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「60錠」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

イボシデニブ薬のグローバル主要企業は、Agios Pharmaceuticalsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、イボシデニブ薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のイボシデニブ薬市場：タイプ別、2018年-2023年、2024年-2029年
世界のイボシデニブ薬市場：タイプ別市場シェア、2022年
・60錠、30錠

世界のイボシデニブ薬市場：用途別、2018年-2023年、2024年-2029年
世界のイボシデニブ薬市場：用途別市場シェア、2022年
・病院、薬局

世界のイボシデニブ薬市場：地域・国別、2018年-2023年、2024年-2029年
世界のイボシデニブ薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるイボシデニブ薬のグローバル売上、2018年-2023年
・主要企業におけるイボシデニブ薬のグローバル売上シェア、2022年
・主要企業におけるイボシデニブ薬のグローバル販売量、2018年-2023年
・主要企業におけるイボシデニブ薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Agios Pharmaceuticals

*************************************************************

・調査・分析レポートの概要
イボシデニブ薬市場の定義
市場セグメント
世界のイボシデニブ薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のイボシデニブ薬市場規模
世界のイボシデニブ薬市場規模：2022年 VS 2029年
世界のイボシデニブ薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのイボシデニブ薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のイボシデニブ薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：60錠、30錠
イボシデニブ薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、薬局
イボシデニブ薬の用途別グローバル売上・予測

・地域別市場分析
地域別イボシデニブ薬市場規模 2022年と2029年
地域別イボシデニブ薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Agios Pharmaceuticals
...

Ivosidenib is an experimental drug for treatment of cancer. It is a small molecule inhibitor of IDH1, which is mutated in several forms of cancer.
This report aims to provide a comprehensive presentation of the global market for Ivosidenib Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ivosidenib Drugs. This report contains market size and forecasts of Ivosidenib Drugs in global, including the following market information:
Global Ivosidenib Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Ivosidenib Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Ivosidenib Drugs companies in 2022 (%)
The global Ivosidenib Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
60 Tablets Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Ivosidenib Drugs include Agios Pharmaceuticals. etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ivosidenib Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ivosidenib Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Ivosidenib Drugs Market Segment Percentages, by Type, 2022 (%)
60 Tablets
30 Tablets
Global Ivosidenib Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Ivosidenib Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Pharmacy
Global Ivosidenib Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Ivosidenib Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ivosidenib Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Ivosidenib Drugs revenues share in global market, 2022 (%)
Key companies Ivosidenib Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Ivosidenib Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Agios Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ivosidenib Drugs, market overview.
Chapter 2: Global Ivosidenib Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Ivosidenib Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ivosidenib Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Ivosidenib Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Ivosidenib Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ivosidenib Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ivosidenib Drugs Overall Market Size
2.1 Global Ivosidenib Drugs Market Size: 2022 VS 2029
2.2 Global Ivosidenib Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Ivosidenib Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Ivosidenib Drugs Players in Global Market
3.2 Top Global Ivosidenib Drugs Companies Ranked by Revenue
3.3 Global Ivosidenib Drugs Revenue by Companies
3.4 Global Ivosidenib Drugs Sales by Companies
3.5 Global Ivosidenib Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Ivosidenib Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Ivosidenib Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Ivosidenib Drugs Players in Global Market
3.8.1 List of Global Tier 1 Ivosidenib Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Ivosidenib Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Ivosidenib Drugs Market Size Markets, 2022 & 2029
4.1.2 60 Tablets
4.1.3 30 Tablets
4.2 By Type – Global Ivosidenib Drugs Revenue & Forecasts
4.2.1 By Type – Global Ivosidenib Drugs Revenue, 2018-2023
4.2.2 By Type – Global Ivosidenib Drugs Revenue, 2024-2029
4.2.3 By Type – Global Ivosidenib Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Ivosidenib Drugs Sales & Forecasts
4.3.1 By Type – Global Ivosidenib Drugs Sales, 2018-2023
4.3.2 By Type – Global Ivosidenib Drugs Sales, 2024-2029
4.3.3 By Type – Global Ivosidenib Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Ivosidenib Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Ivosidenib Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Pharmacy
5.2 By Application – Global Ivosidenib Drugs Revenue & Forecasts
5.2.1 By Application – Global Ivosidenib Drugs Revenue, 2018-2023
5.2.2 By Application – Global Ivosidenib Drugs Revenue, 2024-2029
5.2.3 By Application – Global Ivosidenib Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Ivosidenib Drugs Sales & Forecasts
5.3.1 By Application – Global Ivosidenib Drugs Sales, 2018-2023
5.3.2 By Application – Global Ivosidenib Drugs Sales, 2024-2029
5.3.3 By Application – Global Ivosidenib Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Ivosidenib Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Ivosidenib Drugs Market Size, 2022 & 2029
6.2 By Region – Global Ivosidenib Drugs Revenue & Forecasts
6.2.1 By Region – Global Ivosidenib Drugs Revenue, 2018-2023
6.2.2 By Region – Global Ivosidenib Drugs Revenue, 2024-2029
6.2.3 By Region – Global Ivosidenib Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Ivosidenib Drugs Sales & Forecasts
6.3.1 By Region – Global Ivosidenib Drugs Sales, 2018-2023
6.3.2 By Region – Global Ivosidenib Drugs Sales, 2024-2029
6.3.3 By Region – Global Ivosidenib Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Ivosidenib Drugs Revenue, 2018-2029
6.4.2 By Country – North America Ivosidenib Drugs Sales, 2018-2029
6.4.3 US Ivosidenib Drugs Market Size, 2018-2029
6.4.4 Canada Ivosidenib Drugs Market Size, 2018-2029
6.4.5 Mexico Ivosidenib Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Ivosidenib Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Ivosidenib Drugs Sales, 2018-2029
6.5.3 Germany Ivosidenib Drugs Market Size, 2018-2029
6.5.4 France Ivosidenib Drugs Market Size, 2018-2029
6.5.5 U.K. Ivosidenib Drugs Market Size, 2018-2029
6.5.6 Italy Ivosidenib Drugs Market Size, 2018-2029
6.5.7 Russia Ivosidenib Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Ivosidenib Drugs Market Size, 2018-2029
6.5.9 Benelux Ivosidenib Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Ivosidenib Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Ivosidenib Drugs Sales, 2018-2029
6.6.3 China Ivosidenib Drugs Market Size, 2018-2029
6.6.4 Japan Ivosidenib Drugs Market Size, 2018-2029
6.6.5 South Korea Ivosidenib Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Ivosidenib Drugs Market Size, 2018-2029
6.6.7 India Ivosidenib Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Ivosidenib Drugs Revenue, 2018-2029
6.7.2 By Country – South America Ivosidenib Drugs Sales, 2018-2029
6.7.3 Brazil Ivosidenib Drugs Market Size, 2018-2029
6.7.4 Argentina Ivosidenib Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Ivosidenib Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Ivosidenib Drugs Sales, 2018-2029
6.8.3 Turkey Ivosidenib Drugs Market Size, 2018-2029
6.8.4 Israel Ivosidenib Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Ivosidenib Drugs Market Size, 2018-2029
6.8.6 UAE Ivosidenib Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Agios Pharmaceuticals
7.1.1 Agios Pharmaceuticals Company Summary
7.1.2 Agios Pharmaceuticals Business Overview
7.1.3 Agios Pharmaceuticals Ivosidenib Drugs Major Product Offerings
7.1.4 Agios Pharmaceuticals Ivosidenib Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Agios Pharmaceuticals Key News & Latest Developments
8 Global Ivosidenib Drugs Production Capacity, Analysis
8.1 Global Ivosidenib Drugs Production Capacity, 2018-2029
8.2 Ivosidenib Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Ivosidenib Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Ivosidenib Drugs Supply Chain Analysis
10.1 Ivosidenib Drugs Industry Value Chain
10.2 Ivosidenib Drugs Upstream Market
10.3 Ivosidenib Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Ivosidenib Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Ivosidenib Drugs in Global Market
Table 2. Top Ivosidenib Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Ivosidenib Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Ivosidenib Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Ivosidenib Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Ivosidenib Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Ivosidenib Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Ivosidenib Drugs Product Type
Table 9. List of Global Tier 1 Ivosidenib Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ivosidenib Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Ivosidenib Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Ivosidenib Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Ivosidenib Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Ivosidenib Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Ivosidenib Drugs Sales (K Units), 2024-2029
Table 16. By Application – Global Ivosidenib Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Ivosidenib Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Ivosidenib Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Ivosidenib Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Ivosidenib Drugs Sales (K Units), 2024-2029
Table 21. By Region – Global Ivosidenib Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Ivosidenib Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Ivosidenib Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Ivosidenib Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Ivosidenib Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Ivosidenib Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Ivosidenib Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Ivosidenib Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Ivosidenib Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Ivosidenib Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Ivosidenib Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Ivosidenib Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Ivosidenib Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Ivosidenib Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Ivosidenib Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Ivosidenib Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Ivosidenib Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Ivosidenib Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Ivosidenib Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Ivosidenib Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Ivosidenib Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Ivosidenib Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Ivosidenib Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Ivosidenib Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Ivosidenib Drugs Sales, (K Units), 2024-2029
Table 46. Agios Pharmaceuticals Company Summary
Table 47. Agios Pharmaceuticals Ivosidenib Drugs Product Offerings
Table 48. Agios Pharmaceuticals Ivosidenib Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Agios Pharmaceuticals Key News & Latest Developments
Table 50. Ivosidenib Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 51. Global Ivosidenib Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 52. Global Ivosidenib Drugs Production by Region, 2018-2023 (K Units)
Table 53. Global Ivosidenib Drugs Production by Region, 2024-2029 (K Units)
Table 54. Ivosidenib Drugs Market Opportunities & Trends in Global Market
Table 55. Ivosidenib Drugs Market Drivers in Global Market
Table 56. Ivosidenib Drugs Market Restraints in Global Market
Table 57. Ivosidenib Drugs Raw Materials
Table 58. Ivosidenib Drugs Raw Materials Suppliers in Global Market
Table 59. Typical Ivosidenib Drugs Downstream
Table 60. Ivosidenib Drugs Downstream Clients in Global Market
Table 61. Ivosidenib Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Ivosidenib Drugs Segment by Type in 2022
Figure 2. Ivosidenib Drugs Segment by Application in 2022
Figure 3. Global Ivosidenib Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Ivosidenib Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Ivosidenib Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Ivosidenib Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Ivosidenib Drugs Revenue in 2022
Figure 9. By Type - Global Ivosidenib Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Ivosidenib Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Ivosidenib Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Ivosidenib Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Ivosidenib Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Ivosidenib Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Ivosidenib Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Ivosidenib Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Ivosidenib Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Ivosidenib Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Ivosidenib Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Ivosidenib Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Ivosidenib Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Ivosidenib Drugs Sales Market Share, 2018-2029
Figure 23. US Ivosidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Ivosidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Ivosidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Ivosidenib Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Ivosidenib Drugs Sales Market Share, 2018-2029
Figure 28. Germany Ivosidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Ivosidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Ivosidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Ivosidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Ivosidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Ivosidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Ivosidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Ivosidenib Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Ivosidenib Drugs Sales Market Share, 2018-2029
Figure 37. China Ivosidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Ivosidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Ivosidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Ivosidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Ivosidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Ivosidenib Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Ivosidenib Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Ivosidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Ivosidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Ivosidenib Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Ivosidenib Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Ivosidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Ivosidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Ivosidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Ivosidenib Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Ivosidenib Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Ivosidenib Drugs by Region, 2022 VS 2029
Figure 54. Ivosidenib Drugs Industry Value Chain
Figure 55. Marketing Channels

★調査レポート[世界のイボシデニブ薬市場予測2023-2029：60錠、30錠] (コード：MMG23LY8528)販売に関する免責事項を必ずご確認ください。

★調査レポート[世界のイボシデニブ薬市場予測2023-2029：60錠、30錠]についてメールでお問い合わせ

MarketReport.jp

世界のイボシデニブ薬市場予測2023-2029：60錠、30錠

市場調査レポート・産業資料総合販売サイト www.MarketReport.jp

市場調査レポート・産業資料 総合販売サイト www.MarketReport.jp

市場調査レポート・産業資料総合販売サイト www.MarketReport.jp